Corrigendum
- PMID: 37293712
- PMCID: PMC10398349
- DOI: 10.2217/fon-2021-0176c1
Corrigendum
Erratum for
-
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma.Future Oncol. 2021 Aug;17(22):2847-2855. doi: 10.2217/fon-2021-0176. Epub 2021 May 12. Future Oncol. 2021. PMID: 33975465 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources